Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity

American Journal of Hypertension

Volumn 28, Issue 7, 2015, Pages 847-851

  Joham, Anju E ^a,b   Boyle, Jacqueline A ^a,c   Zoungas, Sophia ^a,b   Teede, Helena J ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c Jean Hailes for Women's Health   (Australia)

Author keywords

blood pressure; hypertension; obesity; PCOS

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NATIONAL HEALTH INSURANCE; OBESITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; AGE; AUSTRALIA; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; HEALTH SURVEY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDY; REPRODUCTION; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGE FACTORS; AUSTRALIA; BLOOD PRESSURE; BODY MASS INDEX; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCTION; RISK FACTORS;

EID: 84936749632     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu251     Document Type: Article

References (20)

1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544-551.
2. Group REACW. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
3. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006; 12:324-332.
4. Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013; 28:777-784.
5. Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 48-53.
6. Joham AE, Ranasinha S, Zoungas S, Moran L, Teede HJ. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab 2014; 99:E447-E452.
7. Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006; 30:45-53.
8. Meyer C, McGrath BP, Teede HJ. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 2005; 90:5711-5716.
9. Zimmermann S, Phillips R, Dunaif A, Finegood D, Wilkenfeld C, Ardeljan M, Gorlin R, Krakoff L. Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J Clin Endocrinol Metab 1992; 75:508-513.
10. Holte J, Gennarelli G, Berne C, Bergh T, Lithell H. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state. Hum Reprod 1996; 11:23-28.
11. Lee C, Dobson AJ, Brown WJ, Bryson L, Byles J, Warner-Smith P, Young AF. Cohort Profile: the Australian Longitudinal Study on Women's Health. Int J Epidemiol 2005; 34:987-991.
12. Brown WJ, Bryson L, Byles JE, Dobson AJ, Lee C, Mishra G, Schofield M. Women's Health Australia: recruitment for a national longitudinal cohort study. Women Health 1998; 28:23-40.
13. Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring) 2013; 21:1526-1532.
14. Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension 2007; 49:1442-1447.
15. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Prog Horm Res 2004; 59:169-205.
16. Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000; 52:595-600.
17. Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985; 61:946-951.
18. Teede HJ, Norman RJ; on behalf of the PCOS Australian Alliance. Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Jean Hailes Foundation for Women's Health: Melbourne, Australia, 2011.
19. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98:4565-4592.
20. Powers J, Loxton D. The impact of attrition in an 11-year prospective longitudinal study of younger women. Ann Epidemiol 2010; 20:318-321.